Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis

Journal article

Open access

Peer reviewed

Shivali Devjani, Priya V Engel, Sogol S Javadi, Brandon Smith and Jashin J Wu

The Lancet (British edition), v 402(10415), pp 1833-1834

18 Nov 2023

PMID: 37980089

Files and links (1)

url

https://doi.org/10.1016/S0140-6736(23)01619-7View

Published, Version of Record (VoR) Open

Dermatitis, Atopic - drug therapy

Double-Blind Method

Humans

Severity of Illness Index

Treatment Outcome

1 Record Views

Title: Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis
Creators: Shivali Devjani - SUNY Downstate College of Medicine, New York, NY, USA
Priya V Engel - California University of Science and Medicine, Colton, CA, USA
Sogol S Javadi - University of California, Los Angeles
Brandon Smith - Drexel University
Jashin J Wu - University of Miami
Publication Details: The Lancet (British edition), v 402(10415), pp 1833-1834
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Dermatology
Web of Science ID: WOS:001124712700001
Scopus ID: 2-s2.0-85176809536
Other Identifier: 991022207053904721

This publication has contributed to the advancement of the following goals:

Source: SDGs in the Output

Data related to this publication, from InCites Benchmarking & Analytics tool: